Anaptysbio (ANAB) Treasury Shares (2016 - 2026)

Anaptysbio has reported Treasury Shares for 6 years, with the latest figure at $471500.0 in Q1 2026.

• For the quarter ending Q1 2026, Treasury Shares rose 60.98% year-over-year to $471500.0; the trailing twelve-month figure through Mar 2026 stood at $471500.0 (up 60.98% YoY), and the FY2024 full-year result was $504500.0, down 76.25% from the prior year.
• Treasury Shares for Q1 2026 stood at $471500.0, down from $490228.0 in the prior quarter.
• The five-year high for Treasury Shares was $2.6 million in Q2 2025, with the low at $292898.0 in Q1 2025.
• Historically, Treasury Shares has averaged $1.3 million across 5 years, with a median of $1.0 million in 2022.
• Annual changes were most pronounced in 2024 — Treasury Shares soared 297.21% — and 2025, when it sank 86.21%.
• Anaptysbio's Treasury Shares stood at $1.0 million in 2022, then surged by 106.47% to $2.1 million in 2023, then sank by 76.25% to $504500.0 in 2024, then dropped by 2.83% to $490228.0 in 2025, then decreased by 3.82% to $471500.0 in 2026.
• The last three Treasury Shares figures came in at $471500.0 (Q1 2026), $490228.0 (Q3 2025), and $2.6 million (Q2 2025), per Business Quant data.